Company Filing History:
Years Active: 2020-2023
Title: Thomas Kündig: Innovator in Allergy Research
Introduction: Thomas Kündig is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of allergy research, particularly in developing compositions aimed at reducing cat allergenicity. With a total of 2 patents, his work has the potential to improve the quality of life for many individuals affected by cat allergies.
Latest Patents: Kündig's latest patents focus on innovative compositions against cat allergies. The first patent describes a method of reducing the allergenicity of a cat, specifically targeting humans exposed to the cat. This invention includes compositions that comprise a virus-like particle (VLP) and at least one Fel d1 protein. These compositions are designed to induce efficient immune responses, particularly antibody responses, in cats, making them useful for the treatment and prevention of cat allergies.
Career Highlights: Thomas Kündig is affiliated with Universität Zürich, where he conducts his research and development work. His dedication to advancing allergy treatment has positioned him as a key figure in this specialized field.
Collaborations: Kündig has collaborated with notable colleagues, including Martin Bachmann and Gary Jennings, who share his commitment to innovative research in allergy solutions.
Conclusion: Thomas Kündig's contributions to allergy research, particularly through his patented compositions, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in allergy treatment and prevention.